4.4 Article

Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases

期刊

NEUROTOXICOLOGY
卷 25, 期 1-2, 页码 101-115

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/S0161-813X(03)00090-1

关键词

3,4-dihydroxyphenylglycolaldehyde; 3,4-dihydroxyphenylacetaldehyde; MAO; catecholamine metabolites; Alzheimer's disease; Parkinson's disease

资金

  1. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036363, R01NS023805] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE ON AGING [R01AG015354] Funding Source: NIH RePORTER
  3. NIA NIH HHS [AG 14390, AG 15354] Funding Source: Medline
  4. NINDS NIH HHS [NS 23805, NS 36363] Funding Source: Medline

向作者/读者索取更多资源

The monoamine oxidase (MAO) metabolites of norepinephrine (NE) or epinephrine (EPI) and of dopamine (DA) are 3,4-dihydroxyphenyglycolaldehye (DOPEGAL) and 3,4-dihydroxyphenylacetaldehyde (DOPAL), respectively. The toxicity of these catecholamine (CA) MAO metabolites was predicted over 50 years ago. However, until our recent chemical synthesis of these CA aldehyde metabolites, the hypothesis about their toxicity could not be tested. The present paper reviews recent knowledge gained about these compounds. Topics to be reviewed include: chemical synthesis and properties of DOPEGAL and DOPAL; in vitro and in vivo toxicity of CA aldehydes; subcellular mechanisms of toxicity; free radical formation by DOPEGAL versus DOPAL; mechanisms of accumulation of CA aldehydes in Alzheimer's disease (AD) and Parkinson's disease (PD) and potential therapeutic targets in Alzheimer's disease and Parkinson's disease. (C) 2003 Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据